On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy: JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

Statin Therapy ◽

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Vascular Risk ◽

Intervention Trial ◽

Lipid Ratios

On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2011.12.035 ◽

2012 ◽

Vol 59 (17) ◽

pp. 1521-1528 ◽

Cited By ~ 60

Author(s):

Samia Mora ◽

Robert J. Glynn ◽

S. Matthijs Boekholdt ◽

Børge G. Nordestgaard ◽

John J.P. Kastelein ◽

...

Keyword(s):

Statin Therapy ◽

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Vascular Risk ◽

Lipid Ratios

Response to Letter Regarding Article, “High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy”

Circulation ◽

10.1161/circulationaha.114.009345 ◽

2014 ◽

Vol 129 (17) ◽

Author(s):

Samia Mora ◽

Robert J. Glynn ◽

Paul M Ridker

Keyword(s):

Statin Therapy ◽

Particle Number ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Vascular Risk ◽

Size Particle

High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy

Circulation ◽

10.1161/circulationaha.113.002671 ◽

2013 ◽

Vol 128 (11) ◽

pp. 1189-1197 ◽

Cited By ~ 139

Author(s):

Samia Mora ◽

Robert J. Glynn ◽

Paul M Ridker

Keyword(s):

Statin Therapy ◽

Particle Number ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Vascular Risk ◽

Size Particle

Letter From Egom Regarding Article, “High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy”

Circulation ◽

10.1161/circulationaha.113.006477 ◽

2014 ◽

Vol 129 (17) ◽

Cited By ~ 3

Author(s):

Emmanuel E. Egom

Keyword(s):

Statin Therapy ◽

Particle Number ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Vascular Risk ◽

Size Particle

Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B: relationships among the different measurements

Scandinavian Journal of Clinical and Laboratory Investigation ◽

10.1080/00365510410003011 ◽

2004 ◽

Vol 64 (8) ◽

pp. 703-708 ◽

Cited By ~ 1

Author(s):

C. Franzini ◽

C. Valente ◽

P. Luraschi

Keyword(s):

Low Density Lipoprotein Cholesterol

Apolipoprotein B ◽

Low Density Lipoprotein ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Comparisons of Apolipoprotein B Levels Estimated by Immunoassay, Nuclear Magnetic Resonance, Vertical Auto Profile, and Non-High-Density Lipoprotein Cholesterol in Subjects With Hypertriglyceridemia (SAFARI Trial)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2011.03.003 ◽

2011 ◽

Vol 108 (1) ◽

pp. 40-46 ◽

Cited By ~ 23

Author(s):

Scott M. Grundy ◽

Gloria Lena Vega ◽

Joanne E. Tomassini ◽

Andrew M. Tershakovec

Keyword(s):

Nuclear Magnetic Resonance ◽

Magnetic Resonance ◽

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Nuclear Magnetic

Low high-density lipoprotein cholesterol and cardiovascular disease: Risk reduction with statin therapy

American Heart Journal ◽

10.1016/j.ahj.2005.03.049 ◽

2006 ◽

Vol 151 (3) ◽

pp. 556-563 ◽

Cited By ~ 24

Author(s):

Robert S. Rosenson

Keyword(s):

Cardiovascular Disease ◽

Statin Therapy ◽

Risk Reduction ◽

Disease Risk ◽

Cardiovascular Disease Risk ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol

A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol

The American Journal of Cardiology ◽

10.1016/j.amjcard.2017.03.255 ◽

2017 ◽

Vol 120 (4) ◽

pp. 569-576 ◽

Cited By ~ 6

Author(s):

Christie M. Ballantyne ◽

Sukrut Shah ◽

Aditi Sapre ◽

Tanya B. Ashraf ◽

Sandra C. Tobias ◽

...

Keyword(s):

Statin Therapy ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Randomized Evaluation

High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol

The American Journal of Cardiology ◽

10.1016/s0002-9149(00)01508-3 ◽

2001 ◽

Vol 87 (6) ◽

pp. 792-793 ◽

Cited By ~ 21

Author(s):

Allan D Sniderman ◽

Gilles R Dagenais ◽

Bernard Cantin ◽

Jean-Pierre Després ◽

Benoı̂t Lamarche

Keyword(s):

Apolipoprotein B ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Plasma Triglycerides ◽

Normal Plasma

The amount of cholesterol relative to apolipoprotein B in low-density lipoproteins relates primarily to high-density lipoprotein cholesterol in children: The Bogalusa Heart Study

Metabolism ◽

10.1016/0026-0495(94)90187-2 ◽

1994 ◽

Vol 43 (8) ◽

pp. 1042-1046 ◽

Cited By ~ 5

Author(s):

Sathanur R. Srinivasan ◽

Weihang Bao ◽

Gerald S. Berenson

Keyword(s):

Apolipoprotein B ◽

Density Lipoprotein ◽

Low Density Lipoproteins ◽

High Density ◽

Lipoprotein Cholesterol ◽

Low Density ◽

Bogalusa Heart Study ◽

Heart Study